世界の神経芽細胞腫治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Neuroblastoma Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z09915 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、神経芽細胞腫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経芽細胞腫治療の種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・神経芽細胞腫治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Seattle Children’s、CureSearch、Texas Children’s、NANT ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：併用化学療法、モノクローナル抗体療法、ワクチン療法、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・神経芽細胞腫治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・神経芽細胞腫治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・神経芽細胞腫治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・神経芽細胞腫治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・神経芽細胞腫治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Neuroblastoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Neuroblastoma Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Neuroblastoma Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Neuroblastoma Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Others

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
Seattle Children’s
CureSearch
Texas Children’s
NANT

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Neuroblastoma Treatment
1.2 Classification of Neuroblastoma Treatment by Type
1.2.1 Overview: Global Neuroblastoma Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Neuroblastoma Treatment Revenue Market Share by Type in 2020
1.2.3 Combination Chemotherapy
1.2.4 Monoclonal Antibody Therapy
1.2.5 Vaccine Therapy
1.2.6 Others
1.3 Global Neuroblastoma Treatment Market by Application
1.3.1 Overview: Global Neuroblastoma Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroblastoma Treatment Market Size & Forecast
1.5 Global Neuroblastoma Treatment Market Size and Forecast by Region
1.5.1 Global Neuroblastoma Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Neuroblastoma Treatment Market Size by Region, (2016-2021)
1.5.3 North America Neuroblastoma Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Neuroblastoma Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Neuroblastoma Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Neuroblastoma Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Neuroblastoma Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuroblastoma Treatment Market Drivers
1.6.2 Neuroblastoma Treatment Market Restraints
1.6.3 Neuroblastoma Treatment Trends Analysis
2 Company Profiles
2.1 Seattle Children’s
2.1.1 Seattle Children’s Details
2.1.2 Seattle Children’s Major Business
2.1.3 Seattle Children’s Neuroblastoma Treatment Product and Solutions
2.1.4 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Seattle Children’s Recent Developments and Future Plans
2.2 CureSearch
2.2.1 CureSearch Details
2.2.2 CureSearch Major Business
2.2.3 CureSearch Neuroblastoma Treatment Product and Solutions
2.2.4 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 CureSearch Recent Developments and Future Plans
2.3 Texas Children’s
2.3.1 Texas Children’s Details
2.3.2 Texas Children’s Major Business
2.3.3 Texas Children’s Neuroblastoma Treatment Product and Solutions
2.3.4 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Texas Children’s Recent Developments and Future Plans
2.4 NANT
2.4.1 NANT Details
2.4.2 NANT Major Business
2.4.3 NANT Neuroblastoma Treatment Product and Solutions
2.4.4 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 NANT Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neuroblastoma Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroblastoma Treatment Players Market Share
3.2.2 Top 10 Neuroblastoma Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Neuroblastoma Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Neuroblastoma Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Neuroblastoma Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Neuroblastoma Treatment Revenue Market Share by Application (2016-2021)
5.2 Neuroblastoma Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Neuroblastoma Treatment Revenue by Type (2016-2026)
6.2 North America Neuroblastoma Treatment Revenue by Application (2016-2026)
6.3 North America Neuroblastoma Treatment Market Size by Country
6.3.1 North America Neuroblastoma Treatment Revenue by Country (2016-2026)
6.3.2 United States Neuroblastoma Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Neuroblastoma Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Neuroblastoma Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Neuroblastoma Treatment Revenue by Type (2016-2026)
7.2 Europe Neuroblastoma Treatment Revenue by Application (2016-2026)
7.3 Europe Neuroblastoma Treatment Market Size by Country
7.3.1 Europe Neuroblastoma Treatment Revenue by Country (2016-2026)
7.3.2 Germany Neuroblastoma Treatment Market Size and Forecast (2016-2026)
7.3.3 France Neuroblastoma Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Neuroblastoma Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Neuroblastoma Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Neuroblastoma Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Neuroblastoma Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region
8.3.1 Asia-Pacific Neuroblastoma Treatment Revenue by Region (2016-2026)
8.3.2 China Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8.3.5 India Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Neuroblastoma Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Neuroblastoma Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Neuroblastoma Treatment Revenue by Type (2016-2026)
9.2 South America Neuroblastoma Treatment Revenue by Application (2016-2026)
9.3 South America Neuroblastoma Treatment Market Size by Country
9.3.1 South America Neuroblastoma Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Neuroblastoma Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Neuroblastoma Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Neuroblastoma Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Neuroblastoma Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country
10.3.1 Middle East & Africa Neuroblastoma Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Neuroblastoma Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Neuroblastoma Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Neuroblastoma Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Neuroblastoma Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Neuroblastoma Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Neuroblastoma Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Neuroblastoma Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Neuroblastoma Treatment Revenue Market Share by Region (2021-2026)
Table 6. Seattle Children’s Corporate Information, Head Office, and Major Competitors
Table 7. Seattle Children’s Major Business
Table 8. Seattle Children’s Neuroblastoma Treatment Product and Solutions
Table 9. Seattle Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. CureSearch Corporate Information, Head Office, and Major Competitors
Table 11. CureSearch Major Business
Table 12. CureSearch Neuroblastoma Treatment Product and Solutions
Table 13. CureSearch Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Texas Children’s Corporate Information, Head Office, and Major Competitors
Table 15. Texas Children’s Major Business
Table 16. Texas Children’s Neuroblastoma Treatment Product and Solutions
Table 17. Texas Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. NANT Corporate Information, Head Office, and Major Competitors
Table 19. NANT Major Business
Table 20. NANT Neuroblastoma Treatment Product and Solutions
Table 21. NANT Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Neuroblastoma Treatment Revenue (USD Million) by Players (2019-2021)
Table 23. Global Neuroblastoma Treatment Revenue Share by Players (2019-2021)
Table 24. Breakdown of Neuroblastoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Neuroblastoma Treatment Players Head Office, Products and Services Provided
Table 26. Neuroblastoma Treatment Mergers & Acquisitions in the Past Five Years
Table 27. Neuroblastoma Treatment New Entrants and Expansion Plans
Table 28. Global Neuroblastoma Treatment Revenue (USD Million) by Type (2016-2021)
Table 29. Global Neuroblastoma Treatment Revenue Share by Type (2016-2021)
Table 30. Global Neuroblastoma Treatment Revenue Forecast by Type (2021-2026)
Table 31. Global Neuroblastoma Treatment Revenue by Application (2016-2021)
Table 32. Global Neuroblastoma Treatment Revenue Forecast by Application (2021-2026)
Table 33. North America Neuroblastoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Neuroblastoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Neuroblastoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Neuroblastoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Neuroblastoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Neuroblastoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Neuroblastoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Neuroblastoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Neuroblastoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Neuroblastoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Neuroblastoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Neuroblastoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Neuroblastoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Neuroblastoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Neuroblastoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Neuroblastoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Neuroblastoma Treatment Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Neuroblastoma Treatment Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Neuroblastoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Neuroblastoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Neuroblastoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Neuroblastoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Neuroblastoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Neuroblastoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Neuroblastoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Neuroblastoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Neuroblastoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Neuroblastoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Neuroblastoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Neuroblastoma Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Neuroblastoma Treatment Picture
Figure 2. Global Neuroblastoma Treatment Revenue Market Share by Type in 2020
Figure 3. Combination Chemotherapy
Figure 4. Monoclonal Antibody Therapy
Figure 5. Vaccine Therapy
Figure 6. Others
Figure 7. Neuroblastoma Treatment Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Neuroblastoma Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Neuroblastoma Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Neuroblastoma Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Neuroblastoma Treatment Revenue Market Share by Region in 2020
Figure 15. North America Neuroblastoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Neuroblastoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Neuroblastoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Neuroblastoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Neuroblastoma Treatment Market Drivers
Figure 20. Neuroblastoma Treatment Market Restraints
Figure 21. Neuroblastoma Treatment Market Trends
Figure 22. Seattle Children’s Recent Developments and Future Plans
Figure 23. CureSearch Recent Developments and Future Plans
Figure 24. Texas Children’s Recent Developments and Future Plans
Figure 25. NANT Recent Developments and Future Plans
Figure 27. Global Neuroblastoma Treatment Revenue Share by Players in 2020
Figure 28. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Neuroblastoma Treatment Revenue Market Share in 2020
Figure 30. Global Top 10 Players Neuroblastoma Treatment Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Neuroblastoma Treatment Revenue Share by Type in 2020
Figure 33. Global Neuroblastoma Treatment Market Share Forecast by Type (2021-2026)
Figure 34. Global Neuroblastoma Treatment Revenue Share by Application in 2020
Figure 35. Global Neuroblastoma Treatment Market Share Forecast by Application (2021-2026)
Figure 36. North America Neuroblastoma Treatment Sales Market Share by Type (2016-2026)
Figure 37. North America Neuroblastoma Treatment Sales Market Share by Application (2016-2026)
Figure 38. North America Neuroblastoma Treatment Revenue Market Share by Country (2016-2026)
Figure 39. United States Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Neuroblastoma Treatment Sales Market Share by Type (2016-2026)
Figure 43. Europe Neuroblastoma Treatment Sales Market Share by Application (2016-2026)
Figure 44. Europe Neuroblastoma Treatment Revenue Market Share by Country (2016-2026)
Figure 45. Germany Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Neuroblastoma Treatment Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Neuroblastoma Treatment Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Neuroblastoma Treatment Revenue Market Share by Region (2016-2026)
Figure 53. China Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Neuroblastoma Treatment Sales Market Share by Type (2016-2026)
Figure 60. South America Neuroblastoma Treatment Sales Market Share by Application (2016-2026)
Figure 61. South America Neuroblastoma Treatment Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Neuroblastoma Treatment Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Neuroblastoma Treatment Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Neuroblastoma Treatment Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Neuroblastoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source

---